CIENCIAS FARMACÉUTICAS

1979

1. PHARMACOKINETICS OF AMIKACIN (BB-K8) IN PATIENTS UNDERGOING HEMODIALYSIS

   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, Vol. 17, Núm. 8, pp. 357-360

2. PHARMACOKINETICS OF AMIKACIN (BB-K8) IN PATIENTS WITH NORMAL OR IMPAIRED RENAL-FUNCTION

   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, Vol. 17, Núm. 4, pp. 171-175

3. PHARMACOKINETICS OF CEFAMANDOLE IN PATIENTS UNDERGOING HEMODIALYSIS

   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, Vol. 17, Núm. 9, pp. 416-420

4. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function

   International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 17, Núm. 4, pp. 171-175

5. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis

   International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 17, Núm. 8, pp. 357-360

6. Pharmacokinetics of cefamandole in patients undergoing hemodialysis

   International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 17, Núm. 9, pp. 416-420

7. Pharmacokinetics of cefoxitin in patients undergoing hemodialysis

   International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 17, Núm. 8, pp. 366-370

8. Pharmacokinetics of cefoxitin in patients with normal or impaired renal function

   European Journal of Clinical Pharmacology, Vol. 16, Núm. 2, pp. 119-124

9. Pharmacokinetics of cephacetrile in patients undergoing haemodialysis

   European Journal of Clinical Pharmacology, Vol. 16, Núm. 1, pp. 49-52